Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity Against Acinetobacter Species

Sulbactam-durlobactam is a pathogen-targeted β-lactam/β-lactamase inhibitor combination in late-stage development for the treatment of Acinetobacter infections, including those caused by multidrug-resistant strains. Durlobactam is a member of the diazabicyclooctane class of β-lactamase inhibitors wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp-Wallace, Krisztina M, McLeod, Sarah M, Miller, Alita A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
SUL-DUR Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150275/
https://www.ncbi.nlm.nih.gov/pubmed/37125470
http://dx.doi.org/10.1093/cid/ciad095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150275/
https://www.ncbi.nlm.nih.gov/pubmed/37125470
http://dx.doi.org/10.1093/cid/ciad095

Ejemplares similares